Jan 19, 2022

Featuring perspectives from Drs Nitin Jain, Anthony Mato, John Pagel and Jennifer Woyach, moderated by Dr John Allan, including the following topics:

• Introduction (0:00)
• Front-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) (5:29)
• Novel Strategies Combining Bruton Tyrosine Kinase (BTK) and Bcl-2 Inhibitors for CLL (29:04)
• Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations (51:49)
• Selection and Sequencing of Available Therapies for R/R Disease (1:13:20)
• Promising Investigational Agents and Strategies (1:37:44)

CME information and select publications